Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)

The American Journal of Cardiology
R B SinghS Rastogi

Abstract

In a randomized, double-blind, placebo-controlled trial, the effects of combined treatment with the antioxidant vitamins A (50,000 IU/day), vitamin C (1,000 mg/day), vitamin E (400 mg/day), and beta-carotene (25 mg/day) were compared for 28 days in 63 (intervention group) and 62 (placebo group) patients with suspected acute myocardial infarction. After treatment with antioxidants, the mean infarct size (creatine kinase and creatine kinase-MB gram equivalents) was significantly less in the antioxidant group than in the placebo group. Serum glutamic-oxaloacetic transaminase decreased by 45.6 IU/dl in the antioxidant group versus 25.8 IU/dl in the placebo group (p < 0.02). Cardiac enzyme lactate dehydrogenase increased slightly (88.6 IU/dl) in the antioxidant group compared with that in the placebo group (166.5 IU/dl) (p < 0.01). QRS score in the electrocardiogram was significantly less in the antioxidant than in the placebo group. The following levels increased in the antioxidant group versus the placebo group, respectively: plasma levels of vitamin E increased by 8.8 and 2.2 mumol/L (p < 0.01), vitamin C increased by 12.6 and 4.2 mumol/L (p < 0.01), beta-carotene increased by 0.28 and 0.06 mumol/L (p < 0.01), and vitamin A incre...Continue Reading

References

Feb 1, 1991·Cardiovascular Research·R A Axford-Gatley, G J Wilson
Mar 1, 1972·British Heart Journal·R HumeW S Hillis
Jan 1, 1984·Annals of Nutrition & Metabolism·M WartanowiczG Okolska
Jun 1, 1981·Circulation Research·L Ceremuzyński
Feb 25, 1995·BMJ : British Medical Journal·E D GrechD R Ramsdale
May 20, 1993·The New England Journal of Medicine·M J StampferW C Willett

❮ Previous
Next ❯

Citations

Aug 13, 2013·BioMed Research International·Ramón RodrigoDaniel Hasson
Apr 6, 2004·Journal of General Internal Medicine·Paul G ShekelleMary Hardy
Mar 17, 2001·Journal of Clinical Pathology·I S Young, J V Woodside
Sep 24, 2009·Vascular Health and Risk Management·Dimitrios Kirmizis, Dimitrios Chatzidimitriou
Jul 1, 1998·Indian Journal of Clinical Biochemistry : IJCB·A P JainL M Srivastava
Jun 15, 2006·Antioxidants & Redox Signaling·Alison C CaveAjay M Shah
Oct 2, 2008·The British Journal of Nutrition·S Honarbakhsh, M Schachter
Nov 15, 2000·International Journal of Cardiology·T RinneH G Olbrich
Sep 12, 2000·Current Cardiology Reports·P K SingalA Belló-Klein
Nov 11, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A Tavani, C La Vecchia
Feb 3, 2000·Free Radical Biology & Medicine·W A Pryor
Apr 28, 1999·Free Radical Biology & Medicine·V P PalaceP K Singal
Aug 26, 1998·Progress in Cardiovascular Diseases·G FeuersteinR R Ruffolo
Apr 9, 2008·Rejuvenation Research·Jean-Christophe CharniotDominique Bonnefont-Rousselot
Mar 7, 2012·Expert Review of Cardiovascular Therapy·Ali A SovariAbraham G Kocheril
Dec 13, 2006·Expert Opinion on Investigational Drugs·Graziano RiccioniNicolantonio D'Orazio
Jan 19, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Erfaneh ShayganniMahmoud Rafieian-Kopaei
Dec 2, 2008·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Niki Katsiki, Christos Manes
Jul 17, 2010·Cardiovascular Therapeutics·Lina BadimonTeresa Padro
Dec 15, 2005·Heart, Lung & Circulation·David J GrieveAjay M Shah
Aug 7, 2002·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Vadim F SagachFrancesco Visioli
Mar 13, 2012·Vascular Pharmacology·Agata SchrammTomasz J Guzik
Aug 1, 1996·Journal of the American College of Cardiology·A K DhallaP K Singal
Nov 13, 2001·Journal of the American College of Cardiology·J ShiteC Liang
Jun 13, 2001·Journal of the American College of Cardiology·K K WitteJ G Cleland
Apr 13, 2001·Journal of the American College of Cardiology·N Khaper, P K Singal
Aug 12, 2009·Lipids in Health and Disease·Breanne M Anderson, David W L Ma
Sep 9, 2008·International Journal of Cardiology·Guy D EslickAlan Bensoussan
Mar 1, 2006·American Heart Journal·Andrew P DeFilippis, Laurence S Sperling
Aug 30, 2008·Journal of the American Medical Directors Association·Barbara J Messinger-RapportJohn E Morley
Sep 10, 2013·International Journal of Cardiology·Roberto Marchioli, Giacomo Levantesi
Oct 26, 2005·American Journal of Preventive Medicine·Ariane KönigSteven M Teutsch
Jun 17, 2004·American Heart Journal·Bonnie B DeanC Noel Bairey Merz
May 5, 2004·The Urologic Clinics of North America·Mark A Moyad, Peter R Carroll
Apr 30, 1998·The Annals of Pharmacotherapy·D M BellL M Lopez
Aug 31, 2002·Diabetes/metabolism Research and Reviews·P J DickinsonA J M Boulton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.